The main goal of treatment in patients with bleeding disorders, including both HA and VWD, is to prevent or lessen severity of bleeding, with broad therapeutic aims to increase plasma FVIII levels in HA, or VWF, and/or FVIII in VWD [12]. Here, F8 is linked to hemorrhagic disease.